Lincoln Pharmaceuticals Ltd Quarterly Results

Gross Sales

154.07

168.18

146.55

161.21

147.28

Excise Duty

0

0

0

0

0

Net Sales

154.07

168.18

146.55

161.21

147.28

Other Operating Income

0

0

0

0

0

Other Income

15.27

-6.88

8.97

9.98

10.41

Total Income

169.34

161.3

155.52

171.19

157.69

Total Expenditure

130.26

141.46

122.89

132.83

124.55

PBIDT

39.08

19.84

32.63

38.36

33.14

Interest

0.21

0.37

0.73

0.35

0.44

PBDT

38.87

19.47

31.91

38.01

32.7

Depreciation

3.48

3.23

3.22

3.22

3.22

Minority Interest Before NP

0

0

0

0

0

Tax

4.12

6.65

8.05

5.12

5.51

Deferred Tax

3.59

-1.98

-0.13

3.33

0.29

Reported Profit After Tax

27.68

11.58

20.77

26.33

23.67

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

27.68

11.58

20.77

26.33

23.67

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

27.68

11.58

20.77

26.33

23.67

EPS (Unit Curr.)

13.82

5.78

10.37

13.15

11.82

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

20.03

20.03

20.03

20.03

20.03

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

25.36

11.79

22.26

23.79

22.5

PBDTM(%)

25.22

11.57

21.77

23.57

22.2

PATM(%)

17.96

6.88

14.17

16.33

16.07